Our studies showed that CML-derived EVs controlled biology of Treg, as they increased suppressive function and forkhead box P3 (Foxp3) level in Treg, which are beneficial for leukemia progression [143]. This evidence concerns the gene FOXP3 and chronic myelogenous leukemia, BCR-ABL1 positive.